melph

I believe Alphabet's earnings could surprise positively if Google Cloud continues delivering strong growth and AI features begin driving higher monetization across Search, Workspace, and Cloud.

The biggest concern remains heavy AI capital spending, but if management demonstrates improving returns on those investments and provides confidence that spending will translate into durable earnings growth, investor sentiment could improve.

With its dominant ecosystem and strong cash generation, I am confident Alphabet remains well positioned to benefit from the long-term AI opportunity.

I have some NetLink NBN Trust shares because NetLink owns the fibre broadband infrastructure that underpins Singapore's digital economy. Its recurring revenue and relatively stable cash flows make it a defensive holding in my portfolio. While growth is likely to remain modest, I value its predictable distributions, resilient business model, and the essential role it plays in connecting homes and businesses across Singapore.

I like Sheng Siong because its business is simple, resilient, and generates consistent cash flow. As a supermarket operator, it benefits from steady demand for everyday essentials regardless of the economic environment. Gradual growth, disciplined operations, healthy balance sheet, and regular dividends make it a dependable long-term holding in my portfolio.

I own the XLV ETF because it offers broad exposure to high-quality healthcare companies across pharmaceuticals, medical devices, healthcare services, and insurance. Healthcare demand tends to remain resilient regardless of the economic cycle. For me, XLV provides diversification, stability, and access to long-term trends such as ageing populations and continued medical innovation.

Novo Nordisk remains a world-class company with leading diabetes and obesity treatments, but I'm re-evaluating my investment. Competition in the obesity market is intensifying, and future growth may become less predictable. I may eventually switch to a healthcare company with a more diversified business and lower execution risk while continuing to monitor Novo Nordisk's progress.

One reason I continue holding Fortinet is that cybersecurity has become a necessity, not a luxury. My investment thesis is that businesses will keep increasing their spending on digital security over time. If Fortinet continues to innovate, expand its platform, and win enterprise customers, I believe it can deliver solid long-term growth despite intense competition.

It's really World Cup fever everywhere in Singapore. The excitement isn't just in sports bars anymore. Free live screenings are being held all over the island....at malls, community plazas, community clubs, SAFRA clubhouses and other public spaces.

People are gathering late into the night to watch the matches together. Friends, families, neighbours and even strangers are cheering, celebrating goals and sharing the excitement. Even if you don't support a particular team, it's hard not to get caught up in the atmosphere.

For a few weeks, football brings everyone together, and you can really feel the World Cup spirit all across Singapore.

As an S&P Global shareholder, I appreciate the company's strong position in credit ratings, financial data, and market analytics. Its recurring revenue and high-quality business model provide resilience across market cycles. The key questions are whether demand for financial data and ratings will continue growing, and whether the company can keep expanding its analytics and index businesses.

As an ELF Beauty shareholder, I like the company's ability to grow by offering trendy, affordable products and responding quickly to changing consumer preferences. Its strong innovation and expanding international presence support long-term potential. The key questions are whether ELF can continue gaining market share, maintain healthy profit margins, and successfully expand beyond its core markets.

As an Eli Lilly shareholder, I am encouraged by the company's leadership in diabetes and weight-loss treatments, which continue to drive strong revenue growth. Its promising drug pipeline also supports long-term potential.

For me, the key questions are whether Eli Lilly can sustain strong earnings growth, maintain its leadership in obesity and diabetes treatments, and continue developing successful new medicines to drive future growth.

As an OCBC shareholder, I appreciate the bank's strong balance sheet, steady dividend payments, and diversified business model. Its exposure to banking, wealth management, and insurance provides resilience across market cycles. While lower interest rates could affect earnings growth, I believe OCBC remains a solid long-term holding that can continue generating value and income for shareholders.

Eli Lilly continues to benefit from strong demand for its diabetes and weight-loss treatments, which have become major growth drivers. The company also has a promising pipeline that could support future earnings growth. However, the stock trades at a premium valuation, meaning investors are expecting continued success in both its current products and future drug development efforts.

Palo Alto Networks remains one of the leading cybersecurity companies as organizations continue to face growing digital threats. Its broad platform strategy helps customers simplify security management and reduce complexity. The company has delivered strong growth over the years, but we need to remember that the stock already reflects high expectations. Future returns will depend on continued growth, innovation, and successful execution in a highly competitive market.

Google continues benefiting from its dominant search, cloud, and AI businesses. However, regulatory scrutiny and the challenge of monetizing AI investments remain key risks.

AMD is steadily expanding its presence in AI and data centers, leveraging strong product execution to challenge larger rivals. However, intense competition and high expectations leave little room for disappointment. Good to be cautious.